v3.25.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Assets:    
Deferred Offering Costs $ 170,882 $ 157,937
Total Assets 170,882 157,937
Current liabilities:    
Accrued offering costs 12,945 0
Promissory note - related party 203,047 184,847
Total Current Liabilities 215,992 184,847
Commitments and Contingencies (Note 6)
Shareholders' Deficit    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding 0 0
Additional paid-in capital 23,964 23,964
Accumulated deficit 70,110 51,910
Total Shareholder's Deficit (45,110) (26,910)
Total Liabilities and Shareholder's Deficit 170,882 157,937
Common Class A [Member]    
Shareholders' Deficit    
Common Stock 0 0
Common Class B [Member]    
Shareholders' Deficit    
Common Stock [1],[2] $ 1,036 $ 1,036
Related Party [Member]    
Current liabilities:    
Notes Payable, Current, Related Party [Extensible Enumeration] Related Party [Member] Related Party [Member]
[1] Includes an aggregate of up to 1,350,000 Class B ordinary shares, $0.0001 par value subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (Note 5). On May 15, 2025, the Company consummated its Initial Public Offering and sold 41.4 million Units, which includes the full exercise of the underwriter’s over-allotment option, hence the 1,350,000 Class B ordinary shares are no longer subject to forfeiture.
[2] On February 15, 2024, the Sponsor acquired an aggregate of 7,187,500 founder shares, acquired for approximately $0.003 per share. In April 2025, the Company effected a share capitalization in the form of a share dividend of approximately 0.2 fully paid Class B ordinary shares for each Class B ordinary share in issue. In May 2025, the Company issued an additional 1,725,000 Class B ordinary shares in a share capitalization, resulting in our Sponsor holding an aggregate of 10,350,000 founder shares. All share and per-share data have been retrospectively presented.